- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT06611618
Analyse av tap av muskelkraft, muskelkraft og nedbrytning av motorisk kontroll for å forutsi risikoen for fall hos pasienter med kneartrose (PowerAGING)
Analisi Della Perdita di Forza e Potenza Muscolare e Del Degrado Del Controllo Motorio Per la Predizione Delle Cadute i Una Popolazione Affetta da Artrosi di Ginocchio
The twofold goal of this study is to understand the link between muscle power, muscle strength, and muscle control degradation with the risk of falling, and to develop a framework for the comprehensive and quantitative assessment of muscle power (and strength) in an elderly population of patients with knee osteoarthritis, who are at higher risk of falling. The main question it aims to answer is:
● Are muscle power and motor control degradation better predictors of falls than muscle strength in the aging population?
Participants will undergo:
- Muscle force assessment on a dynamometer
- Muscle power assessment on a dynamometer and on isntrumented stairs
- Home-based mobility monitoring
- Full lower limb MRI acquisition
- Gait assessment
Studieoversikt
Status
Forhold
Detaljert beskrivelse
Falls are a critical yet common event among the elderly, with huge societal and economic impact (reduced quality of life and high costs for the healthcare system). Experimental measures to quantify the residual muscle strength and power may provide useful information to predict the risk of falls in the elderly. Isometric and isokinetic muscle contractions, performed on a dynamometer or during functional tasks can be collected, together with electromyography (to assess muscle activity) and imaging data (to quantify and characterize muscular tissue).
Such data can be collected at different time points to monitor subjects over time, and to inform virtual representation of the human musculoskeletal system (digital twins) to identify possible motor control deficits. Moreover, this same information can be used to better characterize/assess elder individuals at risk of falling (e.g., subjects with knee osteoarthritis), to prevent future falls.
All subjects enrolled in the PowerAGING study will be followed up for 24 months (5 visits in total: M0, M6, M12, M18 and M24 follow-up). At each visit, a series of experimental tests to quantify muscle power and muscle force, as well as a home-based mobility assessment (via single inertial sensor worn for 5 consecutive days), will be performed. In addition, only at start and end, the subjects will undergo a full lower limb MRI and a gait assessment.
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Lisa Berti, Professor
- Telefonnummer: +390516366529
- E-post: lisa.berti@ior.it
Studer Kontakt Backup
- Navn: Massimiliano Baleani, Engineer
- Telefonnummer: +390516366865
- E-post: massimiliano.baleani@ior.it
Studiesteder
-
-
-
Bologna, Italia, 40136
- Rekruttering
- IRCCS Istituto Ortopedico Rizzoli
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Age between 65 and 80 years
- Kellgren score II e III
- No history of falls in the last 12 months
Exclusion Criteria:
- Any musculoskeletal, neurological, rheumatic or tumoral diseases
- Dementia
- Diabetes
- Inguinal or abdominal hernia
- Severe Hypertension (Level 3)
- Severe Cardio-pulmonary insufficiency
- Diagnosis of Osteonecrosis in the lower limb joints
- Pathologies or physical conditions incompatible with the use of magnetic resonance imaging and electrostimulation (i.e., active and passive implanted biomedical devices, epilepsy, severe venous insufficiency in the lower limbs)
- Previous interventions or traumas to the joints of the lower limb
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Knee Osteoarthritis
Elderly patients with knee osteoarthritis, without a history of falls (in the 12 months prior to enrollment). All subjects will be followed up for 24 months, every 6 months. Muscle force and power assessments, plus a home-based mobility monitoring, will be performed at all visits. Full lower limb MRI and a gait assessment will be performed at first and last visit. |
Isokinetic dynamometry test Stair ascent/descent on instrumented stairs Isometric dynamometry (Maximal Voluntary Isometric Contraction) Mobility monitoring with wearable sensors Full lower limb MRI Motion capture, surface EMG and gorund reaction force data |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Maximal muscle force
Tidsramme: At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
|
Maximal Isometric muscle force from dynamometry test |
At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
|
|
Muscle power
Tidsramme: At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
|
Assessed on the dynamometer and during dynamic tasks |
At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
|
|
Muscle activations
Tidsramme: At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
|
From surface EMG data collected on the dynamometer and during dynamic tasks (gait assessment and stair ascent/descent) |
At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
|
|
Digital Mobility Outcomes
Tidsramme: At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
|
Qualitative and quantiative measures of real-world mobility (e.g., gait speed, stride length) |
At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Musculoskeletal model predictions
Tidsramme: At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
|
Estimates of muscle force and knee joint contact forces |
At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
|
|
Muscle volumes
Tidsramme: From first follow-up visit (Month 6) to last follow-up visit (Month 24)
|
Estimation of muscle volumes (cm3) |
From first follow-up visit (Month 6) to last follow-up visit (Month 24)
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Lisa Berti, Professor, IRCCS Istituto Ortopedico Rizzoli
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- CE-AVEC 204/2024/Sper/IOR
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .